SCHEMBL6162395

SCHEMBL6162395

CC1(C)CCC(=O)c2c(COc3ccccc3)nn(CC(F)(F)F)c21

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
GRM5 P41594 4/20 0.35
POLQ O75417 2/20 0.33
BRD4 O60885 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163500 0.83 CYP1A2 (0.46) CYP1A2GRM5POLQ
SCHEMBL6166255 0.76 PARP1 (0.35)
SCHEMBL6167324 0.75 BRD4 (0.38) CYP1A2BRD4
SCHEMBL6165166 0.74 USP19 (0.33) POLQ
SCHEMBL6166383 0.74 KDM1A (0.34) POLQ
SCHEMBL6167448 0.74 CYP1A2 (0.39) CYP1A2GRM5RAB9A
SCHEMBL6163427 0.74 POLL (0.34) POLQ
SCHEMBL6165739 0.73 AURKA (0.31) GRM5NPC1RAB9A
SCHEMBL6167609 0.72 CDC7 (0.37)
SCHEMBL6161815 0.72 ADORA1 (0.38) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed